Sands Capital Life Sciences Pulse Fund II, L.P. - Jun 30, 2025 SCHEDULE 13G/A Report for Beta Bionics, Inc. Common Stock (BBNX)

Filing Manager
Sands Capital Life Sciences Pulse Fund II, L.P.
Reporting Manager
Sands Capital Life Sciences Pulse Fund II. L.P.
Security
Beta Bionics, Inc. Common Stock
Symbol
BBNX
Shares outstanding
43.5M shares
Disclosed Ownership
3.57M shares
Ownership
8.2%
Form type
SCHEDULE 13G/A
Date filed
8/13/2025, 11:20 AM
Date of event
Jun 30, 2025
Previous filing
Apr 9, 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Sands Capital Life Sciences Pulse Fund II. L.P. 8.2% 3.57M 0 3.57M /s/ Jonathan Goodman Jonathan Goodman, General Counsel of the GP of the GP of Sands Capital Life Sciences Pulse Fund II, L.P.
Sands Capital Alternatives, LLC 8.2% 3.57M 0 3.57M /s/ Jonathan Goodman Jonathan Goodman, General Counsel
SANDS FRANK M. 8.2% 3.57M 0 3.57M /s/ Frank M. Sands Frank M. Sands